A Case Study of Business Strategy on Proton Radiotherapy Apparatus System
Date Issued
2015
Date
2015
Author(s)
Yin, Chi-Yen
Abstract
Despite the progress that has been achieved using modern methods of therapy, cancer currently remains one of the greatest problems within medicine. Proton radiotherapy is one of the most economical methods of treatment for malignant diseases with a relatively high rate of effectiveness. This study aims to examine (1) a worldwide industrial development general view on advanced medical systems; (2) the evolution of global proton beam therapy; (3) how Taiwanese enterprise will be at forefront of delivering the last innovative cancer therapy to emerging markets. Case study methodology was conducted for this interview survey with CEO of biomedical technology incorporation in Taiwan. Medical regulations, industrial policies, and technology patents were observed as three principals in this investigation. Proton beam therapy is an rising form of radiation therapy that can maximize radiation doses to the target tumor, while sparing adjacent healthy tissues. Proton beam radiotherapy apparatus is one of robust radiation oncology technologies which comprising (a) energy selection system; (b) medical accelerator system; (c) beam delivery system; (d) beam output system; (e) gantry system; (f) patient positioning system and (g) robotic couch. Results reveal that the strengths of biomedical technology incorporation are (1) integrated modularized manufacturing ability; (2) medical treatment scheduling and information management; (3) advanced clinical curing system; (4) cost-effective customized products and (5) affordable cancer therapy services. The findings were summarized as the following statements; the business strategy encompasses three dimensions: branding promotion, core technology competence strengthening, and proton radiotherapy medical education hub network establishment. The entire advanced medical system can be conveyed to emerging markets based on“build-operate-transfer”model; the major determinants are (a) initial fundraising management; (b) larger size facility acquired; (c) medical criterion constructing techniques; and (d) strategic alliance with regional hospitals.
Subjects
advance medical system
proton beam radiotherapy
business strategy
SDGs
Type
thesis
File(s)![Thumbnail Image]()
Loading...
Name
ntu-104-P02546001-1.pdf
Size
23.54 KB
Format
Adobe PDF
Checksum
(MD5):c8ad7abe2b6188d13aaf6861bf289477